Hsinchu, Taiwan

Mu-En Chung

This inventor holds 1 USPTO granted patent. Top assignees: Chang Chun Petrochemical Co., Ltd., Chang Chun Plastics Co., Ltd., National Tsing Hua University. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mu-En Chung. Retrieved from https://idiyas.com/inventor/mu-en-chung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mu-En Chung

Introduction

Mu-En Chung is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of genome editing, particularly through his innovative work with the CRISPR/Cas system. His expertise and inventions have the potential to impact various areas of biotechnology and genetic research.

Latest Patents

Mu-En Chung holds a patent for a Cas9 expression plasmid, which is a crucial component of a genome editing system. This plasmid includes a tracrRNA sequence, a Cas9 gene, and a chloramphenicol resistance gene (Cm). The invention is designed to enhance the efficiency of genome editing by applying the Cas9 expression plasmid to a CRISPR/Cas-coupled λ-red recombineering system. This advancement represents a significant step forward in the field of genetic engineering.

Career Highlights

Throughout his career, Mu-En Chung has worked with prominent companies such as Chang Chun Petrochemical Co., Ltd. and Chang Chun Plastics Co., Ltd. His experience in these organizations has contributed to his development as an inventor and researcher in the biotechnology sector.

Collaborations

Some of Mu-En Chung's notable coworkers include I-Hsin Yeh and Hung Wei Li. Their collaborative efforts have likely played a role in advancing their shared research interests and innovations.

Conclusion

Mu-En Chung's contributions to genome editing through his patented inventions highlight his role as a significant figure in the field of biotechnology. His work continues to pave the way for future advancements in genetic research and applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…